ZP, H., HJ, M., H, L., ZX, H., DD, J., YL, S., . . . C, H. (2026). AD16 as a novel therapeutic agent: Mechanisms and efficacy in chronic inflammatory pain management. Brain research bulletin, 234, 111707. https://doi.org/10.1016/j.brainresbull.2025.111707
Chicago Style (17th ed.) CitationZP, Hu, et al. "AD16 as a Novel Therapeutic Agent: Mechanisms and Efficacy in Chronic Inflammatory Pain Management." Brain Research Bulletin 234 (2026): 111707. https://doi.org/10.1016/j.brainresbull.2025.111707.
MLA (9th ed.) CitationZP, Hu, et al. "AD16 as a Novel Therapeutic Agent: Mechanisms and Efficacy in Chronic Inflammatory Pain Management." Brain Research Bulletin, vol. 234, 2026, p. 111707, https://doi.org/10.1016/j.brainresbull.2025.111707.
Warning: These citations may not always be 100% accurate.